QuantumScape’s, Production

QuantumScape’s Production Shift Draws Divergent Market Views

31.12.2025 - 06:11:05

QuantumScape US74767V1098

As 2025 draws to a close, QuantumScape finds itself at the center of conflicting market assessments. The solid-state battery developer's shares, having surrendered some of their December rally, approached the $10 level on Tuesday. This price action contrasts with a recent analysis from Zacks Investment Research, which credits the company with a distinct competitive edge. The core argument posits that QuantumScape's valuation framework is evolving from a pure technology promise to that of a manufacturing entity, driven by its new "Cobra" production process and initial customer revenue.

December 2025 proved to be a significant month for the company, marked by key operational and financial developments. On December 17, QuantumScape announced a Joint Development Agreement with a top-ten global automaker, achieving its final commercial target for the year. This was followed six days later by its transition to a Nasdaq listing, a move expected to enhance its visibility among technology-focused investors.

However, this fundamental progress has been met with near-term skepticism in the trading community. Analysts at FX Leaders noted fading momentum in the final days of December. This sentiment was preceded by HSBC downgrading its rating on the stock from "Hold" to "Reduce." Further contributing to the cautious tone, company director Jeffrey Straubel sold shares worth approximately $1.79 million in early December. Traders point to the stock's gain of over 100% for the year as a source of potential correction.

Zacks Highlights a Trio of Bullish Drivers

The Zacks study, dated December 30, differentiates QuantumScape from competitors such as SES AI. It emphasizes the company's focused strategy on a single solid-state battery architecture, as opposed to rivals pursuing multiple technological paths in parallel.

Should investors sell immediately? Or is it worth buying QuantumScape?

Three specific factors underpin this bullish outlook:

  • The Cobra Manufacturing Process: This new heat treatment method for separators operates 25 times faster than the previous "Raptor" generation—a critical advancement for achieving industrial-scale production volumes.
  • Transition to Revenue-Generating Status: In Q3 2025, QuantumScape recorded $12.8 million in customer billings, formally ending its classification as a "pre-revenue" company.
  • Strengthened Supply Chain: Deepened collaborations with Corning and Murata Manufacturing are aimed at scaling the production of ceramic separators.

According to Zacks, Wall Street's loss estimates for 2026 are being narrowed, suggesting analysts are increasingly modeling QuantumScape as a production-focused business rather than solely a research laboratory.

The $10 Threshold and Future Catalysts

Market technicians are closely watching the $10 per share level, viewing it as a key psychological support zone. A sustained break below this point could accelerate the profit-taking that followed the December surge.

Potential catalysts that could counter the recent downward trend include the delivery of "B-sample" cells from the Cobra process and tangible progress at the Eagle-Line pilot production facility. Additionally, an expansion of the existing licensing agreement with Volkswagen's PowerCo subsidiary is seen as another possible positive development for the stock.

Ad

QuantumScape Stock: Buy or Sell?! New QuantumScape Analysis from December 31 delivers the answer:

The latest QuantumScape figures speak for themselves: Urgent action needed for QuantumScape investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 31.

QuantumScape: Buy or sell? Read more here...

@ boerse-global.de | US74767V1098 QUANTUMSCAPE’S